The Effect of Combined Use of Anti-fibrotic Agent With Platelet Rich Plasma on Skeletal Muscle Healing After Acute Injuries

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 10, 2016

Primary Completion Date

September 5, 2017

Study Completion Date

December 12, 2017

Conditions
PRPLosartanMuscle InjurySport Injury
Interventions
BIOLOGICAL

Autologous platelets rich plasma

30 ml of venous blood were drawn from the participant by means of venipuncture. The collected blood was mixed with 3 ml anti-coagulant acid citrate dextrose in the centrifugation sterile tube. The blood sample was then centrifuged using the centrifugation machine. 3 ml of PRP from the buffy coat layer were loaded in a 5 ml syringe. After local sterilization and draping of the site of injection and under US guidance the hematoma was aspirated from the injury site and the freshly prepared PRP was injected.

COMBINATION_PRODUCT

Autologous platelets rich plasma + oral LOSARTAN administration

in addition to local PRP injection, 50 mg / day of LOSARTAN (Cozaar® 50 mg film-coated tablets) were administrated to the study group orally every morning from day 5 and till day 30 after injury.

All Listed Sponsors
lead

Mostafa Hassanein, Msc

OTHER

NCT05827484 - The Effect of Combined Use of Anti-fibrotic Agent With Platelet Rich Plasma on Skeletal Muscle Healing After Acute Injuries | Biotech Hunter | Biotech Hunter